Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

October 26, 2023
The West Virginia Oncology Society (WVOS) 2023 Fall Conference is a unique opportunity to innovate with peers and engage in discussions that will help shape the future of cancer care across the state. This event will delve into two crucial themes: "The Role of Liquid Biopsies in Oncology: Applications, Hurdles, and Prospects" and "Boosting Rural Trials: Involving Communities and Fostering …
The Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute (the Institute) recently brought together experts from relevant healthcare sectors and Institute leadership for a one-day meeting focused on the application of telemedicine in oncology and, specifically, in delivery of immunotherapy for cancers. The Telemedicine Roundtable, held in December, is one piece of a larger ACCC educational …
Every other Monday, ACCC highlights the latest news, announcements, resources, and innovations from our member cancer programs. To submit your program, visit the Member News Submission Portal and complete a brief form. Tackling Melanoma in Pennsylvania On May 6, the Abramson Cancer Center at Penn Medicine in Philadelphia, PA, opened the Tara Miller Melanoma Center, a new center dedicated to fighting …
While the pandemic continues to disrupt the conduct of cancer research, clinical trials remain crucial to advancing clinical care and providing the latest treatment options to all patients, including those in medically underserved communities. Given its location in the American southwest, Yuma Regional Medical Center (YRMC) Cancer Center has a long history of providing culturally appropriate care for …
Ahead of this year's Prescription Drug User Fee Act (PDUFA) reauthorization, ACCC and 88 other patient and provider advocacy organizations urged congressional leadership to pass legislation that would improve the diversity of enrollment in clinical trials. The letter expresses support for a number of policy proposals, including provisions from the DIVERSE Trials Act (H.R. 5030/S. 2706) and the DEPICT …
Last week – on Thursday, May 3, 2018 – Oncology Care Model (OCM)-participating practices from across the country traveled to the Center for Medicare & Medicaid Services (CMS) offices in Baltimore, Md., for the annual OCM Stakeholder Meeting. The public forum was hosted by a panel of representatives from the Center for Medicare and Medicaid Innovation (CMMI), including Lara Strawbridge, OCM Model …
Support for medical research into prostate treatments and cures has inspired a host of fundraising efforts during the past several decades. One charitable organization has inspired a movement that has transformed the month of November into “Movember” by encouraging men to grow facial hair. The charitable organization’s website proclaims, “In the month formerly known as November, Mo Bros and Mo Sisters …
Last week nearly 100 financial advocates gathered in Philadelphia, Pennsylvania, for the September 29 ACCC Financial Advocacy Network Case-Based Workshop. Whether from academic research cancer centers or community hospitals or practices, participants unanimously agreed that the entire cancer community needs to invest more resources to improve financial advocacy services in cancer programs throughout …
Lung cancer is the leading cause of cancer death and the second-most common cancer detected in both men and women in the U.S. Lung cancer accounts for nearly 25% of all cancer deaths in this country. According to estimates by the American Cancer Society, 235,760 patients will be diagnosed with lung cancer, and 131,880 patients will die of the disease in 2021.
Each year on February 4, the world unites to raise awareness about cancer prevalence and prevention under a global initiative spearheaded by the Union for International Cancer Control. Patients, activists, and associations from around the world come together to promote dialogue about how to enhance cancer detection and treatment. Once again, the Association of Community Cancer Centers (ACCC) is joining …
Led by the Colorado Pharmacists Society and the sponsorship of Colorado state senators Faith Winter and Joann Ginal and Representatives Dylan Roberts and David Ortiz, Senate Bill 94 was signed into law June 24, 2021 by Colorado Governor Jared Polis, greatly expanding the scope of practice for state pharmacy professionals. Read how the expansion of collaborative practice agreements under the new legislation …
Over the last months, my ACCCBuzz blog posts have covered navigation documentation tools, orientation needs, patient education, and the value navigators bring to a cancer program. Navigators support patient-centered, coordinated, streamlined access to care. But what about the support navigators themselves need in order to provide the best possible care for the patients and their families while juggling …
Last June, the Centers for Medicare & Medicaid Services (CMS) announced that nearly 200 physician group practices and 17 health insurance companies had been selected to participate in the Oncology Care Model (OCM), the first oncology-specific alternative payment model (APM) pilot. (According to the latest information on the OCM website, participant numbers now stand at 190 practices and 16 …
Friday, Nov. 1 was a busy day for the Centers for Medicare & Medicaid Services (CMS) and its Center for the Medicare and Medicaid Innovation (CMMI). CMS released the final calendar year (CY) 2020 Hospital Outpatient Prospective System and Physician Fee Schedule final rules. Later that afternoon, CMMI posted an “informal” Request for Information on a proposal for the next iteration of an …
As the cancer care landscape changes and treatment costs continue to rise, many cancer programs are revisiting their financial assistance services. More than just adding financial advocates to their staff, cancer programs are integrating their financial services into the continuum of care to ensure their patients have adequate access to the treatments they require. This two-part blog explores the ACCC …
March 13, 2024
Emerging Influencers in NSCLC: How Can We Apply the Latest Tumor Testing and Treatment Strategies Across Actionable Biomarkers? This live, virtual PER program in partnership with LOS will feature expert faculty presenting on the latest findings supporting the inclusion of novel targeted therapies in the standard of care for NSCLC, as well as insights into new targets that may be actionable in the …
May 8, 2024
Elevate your approach to oncology care at the 2024 RMOS Spring Conference. Join us for a collaborative forum where leading experts converge to explore the evolving landscape in cancer care. Delve into discussions on clinical advances, navigate the intricacies of new and existing treatments, and assess the impact of national policies on state-level initiatives. Don't miss this opportunity to gain valuable …
May 22, 2024
This complimentary dinner event will feature Dr. David Penberthy the Former President of the Association of Cancer Care Centers (ACCC) and a Radiation Oncologist at University of Virginia. Join Dr. Penberthy as he dives into the new frontiers of oncology, examining how AI is transforming the modern workforce, plus hear an update on the recent legislative issues affecting patient care in Wyoming. Reserve …
June 22, 2024
This meeting is presented by the Department of Medicine, Division of Oncology at the Washington University School of Medicine in St. Louis. The course will include multiple presentations developed based on new information presented at the ASCO Annual Meeting. These presentations will be placed in the context of updates in treating and diagnosing malignant diseases, with particular highlights in …
June 29, 2024
This meeting is presented by the Department of Medicine, Division of Oncology at the Washington University School of Medicine in St. Louis. The course will include multiple presentations developed based on new information presented at the ASCO Annual Meeting. These presentations will be placed in the context of updates in treating and diagnosing malignant diseases, with particular highlights in …